PAHO calls for equal access to monkeypox vaccine in countries in the region

- Advertisement -

Amid the outbreak of the disease and difficulties in accessing the immunizer, the Agency announced that it has started negotiations with the only pharmaceutical company that manufactures it, despite limited resources.

PAHO calls for equal access to monkeypox vaccine
PAHO calls for equal access to monkeypox vaccine

Members Pan American Health Organization (PAHO) passed a resolution this Friday to demand fair access. vaccine against monkey flower It already affects 24 countries of the Americas.

- Advertisement -

The decision was approved in a special session this Friday. PAHO Governing Council The organization made a statement.

- Advertisement -

During the session, PAHO director Carissa F. Etienne pointed out that there is currently only a third-generation vaccine against monkeypox, emphasizing that it is made by only one manufacturer, the pharmaceutical company, according to the note. Bavarian Scandinavian .

- Advertisement -

PAHO’s board of directors adopted a resolution requesting director Carissa Etienne to deal with the outbreak. take action to facilitate a coordinated response and support its member states provide access to this vaccine through the organization’s Revolving Fund”.

The agency announced that it is in talks with the only pharmaceutical company that produces the vaccine, despite limited resources.
The agency announced that it is in talks with the only pharmaceutical company that produces the vaccine, despite limited resources.

It also asks countries in the region to recognize this revolving fund as “the most appropriate strategic regional technical mechanism to ensure equitable access to this and other vaccines”.

Although the availability of these vaccines is extremely limited, PAHO started negotiations with Bavarian Nordic to help the countries of the region.

Etienne thought that transmission of the virus could be stopped if some recommendations were followed, such as communicating risks, involving affected communities, and treating and isolating patients, as well as early detection and surveillance. Contact tracing is also required.

But “pre- or post-exposure vaccination can complement other measures,” said Etienne.

PAHO’s technical advisory group recommends that countries prioritize vaccines for certain groups, as well as for close contacts of a confirmed case.

The decision was approved at a special session of the PAHO Governing Council this Friday.
The decision was approved at a special session of the PAHO Governing Council this Friday.

The vast majority of cases occur in men who say they have had sex with men and are infected through exposure through sexual contact.

Symptoms include fever, severe headache, swollen lymph nodes, muscle pain, and a rash that forms blisters and crusts.

The rash is usually concentrated on the face, palms and soles of the feet. The mouth, genitals, and eyes may also be affected.

Symptoms can be mild or severe and usually last for several weeks, during which time the person can infect others. Most people recover within a few weeks without treatment.

world Health Organization PAHO reported (WHO) declared the monkeypox epidemic a public health emergency of international importance on 23 July.

The epidemic began in mid-May and has so far affected 89 countries worldwide.

Until now, 24 countries in the Americas have reported at least 10,000 cases of monkeypox. It represents 36% of global cases, according to the agency’s data.

(with information from EFE and AFP)

Source: Info Bae

- Advertisement -

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

2,061FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles